[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:eosinophil-count":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Eosinophil Count",6,5,[8,16,22,28,35,41],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06979323","Depemokimab Asthma Imaging and Bronchoscopy Sub-Study",[12],"Phase 3","RECRUITING","2026-08-26T02:18:25.327036Z","2026-05-05T02:43:29.588575Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06283966","A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease",[12],"2026-08-26T02:17:09.131534Z","2026-05-05T02:43:29.527616Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06750289","Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment",[12],"2026-08-26T02:16:46.951087Z","2026-05-05T02:43:27.842039Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07323654","A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma",[32],"Phase 2","2026-08-26T02:16:14.341106Z","2026-05-05T02:43:27.640751Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07190209","Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype",[12],"2026-08-26T02:17:54.420226Z","2026-05-05T02:35:31.713460Z",{"nct_id":42,"title":43,"phases":44,"status":45,"updated_at":46,"content_modified":47},"NCT06940154","Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)",[32],"ACTIVE_NOT_RECRUITING","2026-08-03T03:06:01.435370Z","2026-06-16T05:54:07.928811Z"]